Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma?

Author： Le Pchoux C.   Musat E.   Baey C.   Al Mokhles H.   Terrier P.   Domont J.   Le Cesne A.   Laplanche A.   Bonvalot S.  

Publisher： Oxford University Press

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.3, 2013-03, pp. : 832-837

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant radiation therapy of retroperitoneal sarcoma: the role of intraoperative radiotherapy (IORT)

By Hu Kenneth S.   Harrison Louis B.  

Sarcoma, Vol. 4, Iss. 1-2, 2000-03 ,pp. : 11-16

Informa Healthcare

Access to resources Recommend Favorite

Should bisphosphonates be utilized in the adjuvant setting for breast cancer?

By Lipton Allan  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 627-636

Springer Publishing Company

Access to resources Recommend Favorite

Selection of Primary Breast Cancer Patients for Adjuvant Endocrine Therapy – is Oestrogen Receptor Alone Adequate?

By Cheung K.L.  

Breast Cancer Research and Treatment, Vol. 65, Iss. 2, 2001-01 ,pp. : 155-162

Springer Publishing Company

Access to resources Recommend Favorite

Patients with Recurrent Breast Cancer: Does the Primary Axillary Lymph node Status Predict more Aggressive Tumor Progression?

By Rack Brigitte  

Breast Cancer Research and Treatment, Vol. 82, Iss. 2, 2003-01 ,pp. : 83-92

Springer Publishing Company

Access to resources Recommend Favorite

Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried Out at High-Volume Centers is Safe and is Associated With Improved Local Control

By Bonvalot Sylvie  

Annals of Surgical Oncology, Vol. 17, Iss. 6, 2010-06 ,pp. : 1507-1514

Springer Publishing Company

Access to resources Recommend Favorite